Larson Financial Group’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Larson Financial Group’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-124	Closed	-$1.95K	–	2508
2024 Q1	$1.95K	Sell	124 -53	-30%	-$816	﹤0.01%	1363
2023 Q4	$2.85K	Hold	177	–	–	﹤0.01%	1303
2023 Q3	$2.25K	Hold	177	–	–	﹤0.01%	1340
2023 Q2	$2.49K	Hold	177	–	–	﹤0.01%	1235
2023 Q1	$2.73K	Hold	177	–	–	﹤0.01%	1199
2022 Q4	$2.9K	Hold	177	–	–	﹤0.01%	1136
2022 Q3	$3K	Sell	177 -1,002	-85%	-$15.7K	﹤0.01%	1082
2022 Q2	$16K	Buy	+1,179	New	+$13K	﹤0.01%	608

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Larson Financial Group's DCPH Position: Q2 2024 in Review

Larson Financial Group sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 124 shares — an estimated $1.95K sold.

Larson Financial Group first reported a position in DCPH in Q2 2022 and held it in 8 quarters. The position peaked at $16K in Q2 2022. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Larson Financial Group reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Larson Financial Group sold 124 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $1.95K.
Larson Financial Group first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q2 2022 and held it in 8 quarters.
Larson Financial Group's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $16K in Q2 2022.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Larson Financial Group's 13F filing for Q2 2024, filed 2 Aug 2024.